BioCentury | Oct 24, 2020
Finance
Oct. 23 Quick Takes: RA Capital’s $461M new fund; plus venture rounds for Sirnaomics, 3D Medicines, Zhaoke, Orbus, Araris
...and undisclosed series A investors.Orbus tops off series A, adds von Emster to boardBay Area-based Orbus Therapeutics Inc....
...btov Partners and existing investors Redalpine, VI Partners and Schroder Adveq also invested. BC Staff Araris Biotech AG Orbus Therapeutics Inc. 3D...
...btov Partners and existing investors Redalpine, VI Partners and Schroder Adveq also invested. BC Staff Araris Biotech AG Orbus Therapeutics Inc. 3D...